Description
Target Visceral Fat, Boost Growth Hormone, and Improve Body Composition
FDA-Approved Peptide Therapy for Metabolic Health and Fat Reduction
Tesamorelin is a potent growth hormone–releasing peptide clinically proven to reduce visceral fat—the deep abdominal fat linked to metabolic disease, inflammation, and cardiovascular risk. It also enhances IGF-1 levels, supporting fat loss, lean muscle maintenance, and improved metabolic function.
Why Clients Love Tesamorelin:
- Reduction in Visceral Fat – Specifically targets dangerous deep belly fat that surrounds internal organs.
- Increased IGF-1 + Growth Hormone – Stimulates natural GH production for better fat metabolism, tissue repair, and anti-aging effects.
- Muscle Preservation + Lean Mass Support – Helps retain and build lean muscle while losing fat.
- Improved Metabolic Health – Supports insulin sensitivity, lipid balance, and reduced inflammation.
- FDA-Approved for Lipodystrophy – Backed by clinical research with a strong safety profile.